Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve and take on record Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2026

GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com November 06th, 2026 BSE Limited 1st Floor, New Trading Ring, Rotunda Building, P.J. Towers, Dalal Street, Fort, Mumbai – 400 001 BSE Code: 530317 Dear Sir/Madam, Sub: Intimation of the Board Meeting of Godavari Drugs Limited (the ‘Company’) to be held on Wednesday, November 11, 2026. Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 11, 2026, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, along with other business items, if any. Closure of Trading Window Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, read with the SEBI (Prohibition of Insider Trading) Regulations, 2015, it was already informed, vide our earlier communication dated September 21, 2026, that the Trading Window for dealing in the Company’s securities shall remain closed till 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, for all designated persons and their immediate relatives. This is for your information and records. Yours faithfully, For Godavari Drugs Limited CS VENKATESH ACHANTA Company Secretary and Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L21001TG1987PLC008016